Evidence map›Paper›PMID 27239863›Full record

ArticleInternational journal of health policy and management2015

Priority Setting for Improvement of Cervical Cancer Prevention in Iran.

Azam Majidi, Reza Ghiasvand, Maryam Hadji, Azin Nahvijou, Azam-Sadat Mousavi, Minoo Pakgohar, Nahid Khodakarami, Mehrandokht Abedini, Farnaz Amouzegar Hashemi, Marjan Rahnamaye Farzami and 8 more

Open access · diamondAbstract read
In one paragraph

Article in International journal of health policy and management, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Spousal sexual life issues after gynecological cancer: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 5 countries.

Azam MajidiCancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Reza GhiasvandCancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Maryam HadjiCancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Azin NahvijouCancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Azam-Sadat MousaviDepartment of Genecology Oncology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Minoo PakgoharDepartment of Reproductive Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran.
Nahid KhodakaramiCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehrandokht AbediniDeputy of Public Health, Maternal Office, Ministry of Health and Medical Education, Tehran, Iran.
Farnaz Amouzegar HashemiRadiotherapy Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Marjan Rahnamaye FarzamiCentral Reference Laboratory, Ministry of Health and Medical Education, Tehran, Iran.
Reza ShahsiahDepartment of Pathology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Sima SajedinejhadDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Ali MohagheghiCancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh NadaliFaculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Arash RashidianDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Elisabete WeiderpassDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Ole MogensenDepartment of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark.
Kazem ZendehdelCancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRMotamed Cancer Institute · IRMinistry of Health and Medical Education · IRIran University of Medical Sciences · IROdense University Hospital · DKShahid Beheshti University of Medical Sciences · IRUiT The Arctic University of Norway · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is the fourth most common cancer among women worldwide. Organized cervical screening and vaccination against human papilloma virus (HPV) have been successful interventions for prevention of invasive cervical cancer (ICC). Because of cultural and religious considerations, ICC has low incidence in Iran and many other Muslim countries. There is no organized cervical screening in these countries. Therefore, ICC is usually diagnosed in advanced stages with poor prognosis in these countries. We performed a priority setting exercise and suggested priorities for prevention of ICC in this setting.

methodsWe invited experts and researchers to a workshop and asked them to list important suggestions for ICC prevention in Iran. After merging similar items and removing the duplicates, we asked the experts to rank the list of suggested items. We used a strategy grid and Go-zone analysis to determine final list of priorities for ICC prevention in Iran.

resultsFrom 26 final items suggested as priorities for prevention of ICC, the most important priorities were developing national guidelines for cervical screening and quality control protocol for patient follow-up and management of precancerous lesions. In addition, we emphasized considering insurance coverage for cervical screening, public awareness, and research priorities, and establishment of a cervical screening registry.

conclusionA comprehensive approach and implementation of organized cervical screening program is necessary for prevention of ICC in Iran and other low incidence Muslim countries. Because of high cost for vaccination and low incidence of cervical cancer, we do not recommend HPV vaccination for the time being in Iran.

Indexed as

AwarenessCost-Benefit AnalysisEarly Detection of CancerFemaleHealth PolicyHealth PrioritiesHumansIncidenceInsurance, Health, ReimbursementIranPractice Guidelines as TopicPublic Health SurveillanceQuality ControlRegistriesUterine Cervical NeoplasmsInvasive Cervical Cancer (ICC)IranPrevention and ControlPriority SettingScreening

Identifiers

PMID27239863
PMCPMC4818987
OpenAlexW2180698580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.